Longer hormone treatment may improve moderate prostate cancer
Friday, June 12th, 2009 Posted in hormone therapy | No Comments »A new European study has found that men with moderately advanced prostate cancer who get hormone-blocking drugs after radiation therapy do better when the drug treatment is continued for two or more years after an initial six-month regimen. The results apply ...
Quality of life for prostate cancer patients
Thursday, June 11th, 2009 Posted in prostatectomy, radiation therapy | No Comments »A long-term study by researchers at UCLA's Jonsson Comprehensive Cancer Center found that the three most common treatments for localized prostate cancer had significant impacts on patients' quality of life, a finding that could help guide doctors and patients in ...
European management of T3 prostate cancer
Wednesday, June 10th, 2009 Posted in prostate cancer | No Comments »The gold standard treatment for clinical stage T3 prostate cancer has long been the combination of radiotherapy and extended hormone therapy. However, the accuracy of clinical staging based on DRE is open to some question, since 20 percent of patients ...
Hormone therapy makes prostate tumour becoming more aggressive and more liable to form metastases
Wednesday, June 10th, 2009 Posted in hormone therapy | No Comments »One of the conclusion of a thesis presented at the Sahlgrenska Academy, University of Gothenburg, Sweden, shows that hormone therapy is often given to patients with advanced prostate cancer. While it is true that the treatment prevents growth of the tumour, ...
Ultrasound may be more precise when obliterates prostate tumours
Tuesday, June 9th, 2009 Posted in hifu, radiation therapy | No Comments »Surgeons at the North Hampshire Hospital in Basingstoke say the high-powered beam of ultrasound is so precise that it obliterates tumours without damaging delicate surrounding tissues, including the nerves that are critical for male sexual function. Conventional surgery or radiotherapy leave ...
New review: bisphosphonate therapy and osteonecrosis of the jaw
Monday, June 8th, 2009 Posted in hormone therapy | No Comments »Many doctors advise cancer patients to use bisphosphonate therapy to prevent bone loss and other bone-related adverse events associated with long-term hormonal therapy. A disorder now known as bisphosphonate-related osteonecrosis of the jaw (BRONJ) was initially associated with bisphosphonate therapy ...
About the impact that prostate cancer has on a man’s love life
Sunday, June 7th, 2009 Posted in prostate cancer | No Comments »A man is supposed to be physically healthy and emotionally strong. So where does he turn to when a disease such as prostate cancer comes along, which threatens this? Although prostate cancer strikes only men, it can have a profound impact ...
Uniform scanning decreases risks of radiation therapy
Saturday, June 6th, 2009 Posted in radiation therapy | No Comments »Doctors at the University of Florida Proton Therapy Institute are using a new technique called uniform scanning. It moves a single beam of protons in a sweeping or scanning motion, enabling the beam to reach deeper into the body and ...
Serum calcium levels aren’t a risk factor for prostate cancer
Friday, June 5th, 2009 Posted in prostate cancer risks | No Comments »Previous findings have suggested an association between high levels of serum calcium and a high risk of prostate cancer death. Recently, an analysis of historical specimens from a large Swedish database suggests that there is no reason to believe that ...
Diet low in fat and red meat may reduce risk of prostate cancer
Thursday, June 4th, 2009 Posted in prostate cancer risks | No Comments »Acording to a new review published in the Journal of Human Nutrition and Dietetics a diet low in fat, high in vegetables and fruit, and avoiding high energy intake, excessive meat, and excessive dairy products and calcium intake may be ...